Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06476613 · ClinicalTrials.gov registry record · NA

Permissive Hypotension After Cardiac Surgery

A NA study of Surgery, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06476613 is a NA study of Surgery that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06476613, a NA study of Surgery, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The objective of this pilot randomized controlled trial is to demonstrate the feasibility of implementing a pragmatic clinical trial randomizing patients to permissive hypotension versus usual care and to determine the impact of permissive hypotension on vasopressor exposure, ICU length of stay, markers of end organ perfusion, and clinically relevant patient outcomes. The data collected from this pilot study will be used as preliminary data for study design and grant applications for a larger multicenter randomized controlled trial.

Conditions Studied

Interventions

  • OTHER Permissive Hypotension

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-04-20
Est. Completion 2026-10-01
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06476613

The ClinicalTrials.gov registry entry for NCT06476613 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Permissive Hypotension is the first listed.

NCT06476613 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06476613 about?

NCT06476613 is a clinical study titled "Permissive Hypotension After Cardiac Surgery". The objective of this pilot randomized controlled trial is to demonstrate the feasibility of implementing a pragmatic clinical trial randomizing patients to permissive hypotension versus usual care and to determine the impact of permissive hypotension on vasopressor exposure, ICU length of stay, mar...

What is the current status of trial NCT06476613?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-04-20. Estimated completion is 2026-10-01.

What conditions does trial NCT06476613 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT06476613?

The interventions under investigation include: Permissive Hypotension (OTHER).

Who is sponsoring clinical trial NCT06476613?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06476613 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.